March 1, 2023
Any amount of exercise in middle age is associated with better cognition in later life, new research suggests. A prospective study of 1400 participants showed that […]
March 1, 2023
Adverse childhood experiences (ACEs) are associated with increased motor and nonmotor symptoms of Parkinson’s disease (PD) and reduced quality of life (QOL), new research shows. Results […]
March 1, 2023
SAN DIEGO ― Experts are leading a new initiative to drive home the message that clinicians must consider multiple sclerosis (MS) in the differential diagnosis of […]
March 1, 2023
The US Food and Drug Administration (FDA) has approved the first treatment for the neurodegenerative disorder Friedreich’s ataxia for use in adults and adolescents aged 16 […]
February 28, 2023
Weight loss from intermittently cutting calories has a positive effect on cognitive, immunologic, and other outcomes for patients with multiple sclerosis (MS), new research suggests. Dr […]
February 28, 2023
SAN DIEGO — The prevalence of psychiatric morbidity is significantly higher among patients with multiple sclerosis (MS) vs controls in each of the 5 years prior […]
February 27, 2023
(Reuters) – A U.S. appeals court ordered Jazz Pharmaceuticals Inc on Friday to de-list a patent related to its blockbuster narcolepsy drug Xyrem from the U.S. […]
February 27, 2023
Middle-aged smokers are far more likely to report having memory loss and confusion than nonsmokers, according to researchers at Ohio State University. What to know: Using […]
February 24, 2023
SAN DIEGO — Cognitive behavioral therapy (CBT), the wakefulness-promoting drug modafinil (Provigil), and a combination of both treatments all reduce fatigue in patients with multiple sclerosis […]